Skip to main content
NUFORMIX PLC logo

NUFORMIX PLC — Investor Relations & Filings

Ticker · NFX ISIN · GB00BYW79Y38 LEI · 2138003XG3H3I2J3BJ24 IL Professional, scientific and technical activities
Open in API
Filings indexed 279 across all filing types
Latest filing 2019-09-10 AGM Information
Country GB United Kingdom
Listing IL NFX

About NUFORMIX PLC

https://www.nuformix.com/

Nuformix PLC is a pharmaceutical development company focused on drug repurposing to address unmet medical needs, particularly in fibrosis and oncology. The company utilizes its expertise in cocrystal technology to unlock the therapeutic potential of approved drugs. This strategy involves creating new solid forms of existing medicines to improve their physical properties and performance, aiming to develop novel treatments with potentially accelerated development timelines.

Recent filings

Filing Released Lang Actions
AGM Results
AGM Information Classification · 1% confidence The document explicitly states it is the 'Result of Annual General Meeting' and details the voting outcomes for various resolutions presented to shareholders, including the reception of the annual report and the re-appointment of directors. This content directly aligns with the purpose of reporting the results of a general meeting. The presence of the RNS Number and the reference to the London Stock Exchange confirms it is a regulatory announcement related to a shareholder meeting. The most specific category for reporting voting results from a general meeting is 'Declaration of Voting Results & Voting Rights Announcements' (DVA). While it mentions the AGM, the core content is the vote tally, not the AGM presentation itself (AGM-R) or the proxy solicitation materials (PSI).
2019-09-10 English
Directorate Change
Regulatory Filings Classification · 1% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content announces the resignation of a director and the withdrawal of a resolution from the upcoming Annual General Meeting (AGM). While it mentions the AGM, the primary function of this short announcement is to disseminate immediate, material information via the Regulatory Information Service (RNS). Since it is a general regulatory announcement that doesn't fit a more specific category like Board/Management Information (MANG) or AGM Information (AGM-R) which usually contain detailed materials, the most appropriate classification based on the source and nature of the dissemination is Regulatory Filings (RNS). The document length is short (3117 chars), supporting the idea that it is an announcement rather than a full report.
2019-09-10 English
Special Resolutions passed at AGM
AGM Information Classification · 1% confidence The document explicitly states it contains the 'Resolutions of NUFORMIX PLC At the Annual General Meeting' held on 10 September 2019. It details Ordinary Resolutions (like authorizing share allotment under section 551) and Special Resolutions (like empowering directors for equity allotment under section 570 and authorizing market purchases/share buybacks under section 701). This content is the formal record of decisions made during an AGM, which aligns perfectly with the definition of 'AGM Information' (AGM-R). It is not a general earnings release (ER), a full annual report (10-K), or a proxy statement (PSI), but the outcome of the meeting itself.
2019-09-10 English
Ebers Cannabinoid Collaboration Update
M&A Activity Classification · 1% confidence The document begins with an 'RNS Number' and is dated 09 September 2019. It announces an update regarding a strategic collaboration and a first patent filing, which is material non-public information disclosed under Market Abuse Regulation (MAR). The presence of the RNS Number and the explicit mention that the information was released via a Regulatory Information Service (RIS) strongly indicates this is a regulatory announcement. Since it is a general announcement of corporate activity (collaboration update/patent filing) that doesn't fit specific categories like Director's Dealing (DIRS), Earnings Release (ER), or Capital Change (SHA), the most appropriate classification is the general regulatory filing category, RNS.
2019-09-09 English
Appointment of Dr Muhunthan Thillai
Regulatory Filings Classification · 1% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content announces the appointment of a new member to the Scientific Advisory Board, which constitutes a material change in management/governance structure. While it relates to management/board structure, the primary function of this specific announcement format (RNS) is to disseminate timely, material information to the market. Since the content is an announcement of an appointment (Board/Management Information - MANG), but it is delivered via the RNS system, and the document is short and clearly an official regulatory news service release, the most precise classification based on the delivery mechanism and general nature of the announcement is Regulatory Filings (RNS), as it is a standard regulatory news service release that doesn't fit a more specific periodic report category (like 10-K or IR). However, given the specific definition for 'Board/Management Information' (MANG) covers 'Announcement of changes in the company's board of directors or senior management,' and this is exactly what the document details, MANG is a stronger fit than the general RNS fallback, especially since the document length is substantial enough (7008 chars) not to trigger the RPA/RNS rule based on being a mere pointer to a report. The core subject is a management/advisory board change.
2019-09-06 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled with an 'RNS Number' and contains the header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership (crossing thresholds) to the relevant regulatory body (FCA in this case). This directly corresponds to the definition of 'Major Shareholding Notification' (MRQ). Although it is distributed via RNS, the core content is a specific regulatory filing about share ownership change, making MRQ the most precise classification over the general RNS fallback.
2019-09-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.